Guangzhou Wondfo Biotech Co.,Ltd

SZSE:300482 Stock Report

Market Cap: CN¥12.6b

Guangzhou Wondfo BiotechLtd Future Growth

Future criteria checks 5/6

Guangzhou Wondfo BiotechLtd is forecast to grow earnings and revenue by 26.3% and 20.4% per annum respectively. EPS is expected to grow by 25% per annum. Return on equity is forecast to be 13.7% in 3 years.

Key information

26.3%

Earnings growth rate

25.0%

EPS growth rate

Medical Equipment earnings growth23.8%
Revenue growth rate20.4%
Future return on equity13.7%
Analyst coverage

Low

Last updated30 Aug 2024

Recent future growth updates

Recent updates

Cautious Investors Not Rewarding Guangzhou Wondfo Biotech Co.,Ltd's (SZSE:300482) Performance Completely

Sep 06
Cautious Investors Not Rewarding Guangzhou Wondfo Biotech Co.,Ltd's (SZSE:300482) Performance Completely

Returns On Capital At Guangzhou Wondfo BiotechLtd (SZSE:300482) Paint A Concerning Picture

Jul 27
Returns On Capital At Guangzhou Wondfo BiotechLtd (SZSE:300482) Paint A Concerning Picture

Guangzhou Wondfo BiotechLtd's (SZSE:300482) Solid Earnings May Rest On Weak Foundations

Apr 29
Guangzhou Wondfo BiotechLtd's (SZSE:300482) Solid Earnings May Rest On Weak Foundations

A Piece Of The Puzzle Missing From Guangzhou Wondfo Biotech Co.,Ltd's (SZSE:300482) Share Price

Mar 27
A Piece Of The Puzzle Missing From Guangzhou Wondfo Biotech Co.,Ltd's (SZSE:300482) Share Price

There Are Reasons To Feel Uneasy About Guangzhou Wondfo BiotechLtd's (SZSE:300482) Returns On Capital

Feb 29
There Are Reasons To Feel Uneasy About Guangzhou Wondfo BiotechLtd's (SZSE:300482) Returns On Capital

Earnings and Revenue Growth Forecasts

SZSE:300482 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20264,7751,013N/A1,0864
12/31/20253,951818N/A9184
12/31/20243,265648N/A9504
6/30/20242,852509230624N/A
3/31/20242,794502289664N/A
12/31/20232,765488-104329N/A
9/30/20232,989357116569N/A
6/30/20233,136354-56459N/A
3/31/20233,8874971,2681,818N/A
1/1/20235,6811,1971,0991,682N/A
9/30/20225,5501,2479051,472N/A
6/30/20225,5381,2578981,461N/A
3/31/20225,2901,383-270287N/A
12/31/20213,361634208665N/A
9/30/20213,14569518621N/A
6/30/20213,060741-1557N/A
3/31/20212,956692113594N/A
12/31/20202,8116346421,062N/A
9/30/20202,821663657886N/A
6/30/20202,7116308851,053N/A
3/31/20202,172413595775N/A
12/31/20192,072387131310N/A
9/30/20191,921375175329N/A
6/30/20191,817352137296N/A
3/31/20191,74832597232N/A
12/31/20181,650308117248N/A
9/30/20181,54228069198N/A
6/30/20181,49826475175N/A
3/31/20181,323231N/A186N/A
12/31/20171,145211N/A169N/A
9/30/2017921181N/A51N/A
6/30/2017747174N/A100N/A
3/31/2017624154N/A116N/A
12/31/2016547145N/A112N/A
9/30/2016525158N/A143N/A
6/30/2016486147N/A141N/A
3/31/2016450131N/A145N/A
12/31/2015429125N/A132N/A
9/30/2015382106N/A108N/A
6/30/2015380105N/A99N/A
3/31/201536596N/A107N/A
12/31/201436598N/A104N/A
12/31/201324859N/A101N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 300482's forecast earnings growth (26.3% per year) is above the savings rate (2.9%).

Earnings vs Market: 300482's earnings (26.3% per year) are forecast to grow faster than the CN market (23.3% per year).

High Growth Earnings: 300482's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: 300482's revenue (20.4% per year) is forecast to grow faster than the CN market (13.2% per year).

High Growth Revenue: 300482's revenue (20.4% per year) is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 300482's Return on Equity is forecast to be low in 3 years time (13.7%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y